Although rapid tumor proliferation leads to overproduction of angiogenic factors3,51, there is compelling experimental in vitro evidence suggesting that the antiproliferative effects of folic acid treatment on human cell lines are mediated by the folate receptor (FR)/cSrc/ERK/NFκB/P53 pathway28. Here, NFKB1 is linked to neoplasm.